Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Unknown 4Not yet recruiting 3Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Small Cell Lung Carcinoma 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × HLX07 × Clear all
NCT04297995 2023-08-08

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

Shanghai Henlius Biotech

Phase 2 Unknown
131 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05360368 2022-05-05

HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors

Shanghai Henlius Biotech

Phase 1 Unknown
24 enrolled
Other solid neoplasm

Solid Tumor

NCT05354700 2022-05-04

A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer

Shanghai Henlius Biotech

Phase 2 Unknown
20 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05246982 2022-05-02

HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer

Shanghai Henlius Biotech

Phase 2 Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡